UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Haematologica (Roma), 2013-02, Vol.98 (2), p.179-184

2013

Volltextzugriff (PDF)

Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning

Bone marrow transplantation (Basingstoke), 2005-06, Vol.35 (12), p.1195-1200

2005

Volltextzugriff (PDF)

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

The New England journal of medicine, 2018-01, Vol.378 (1), p.35-47

2018

Volltextzugriff (PDF)

Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2001-10, Vol.28 (7), p.689-692

2001

Volltextzugriff (PDF)

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

Bone marrow transplantation (Basingstoke), 2001-02, Vol.27 (4), p.437-444

2001

Volltextzugriff (PDF)

Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'

Bone marrow transplantation (Basingstoke), 2005-10, Vol.36 (7), p.565-574

2005

Volltextzugriff (PDF)

Endoscopic evaluation for cytomegalovirus enterocolitis after allogeneic haematopoietic stem cell transplantation

Gut, 2006-06, Vol.55 (6), p.895-896

2006

Volltextzugriff (PDF)

Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation

Bone marrow transplantation (Basingstoke), 2003-09, Vol.32 (6), p.601-608

2003

Volltextzugriff (PDF)

Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (3), p.279-289

2004

Volltextzugriff (PDF)

Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin

Bone marrow transplantation (Basingstoke), 2002-02, Vol.29 (3), p.237-241

2002

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2011-04, Vol.11 (4), p.284-292

2011

Volltextzugriff (PDF)

Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity

Bone marrow transplantation (Basingstoke), 1999-06, Vol.23 (12), p.1217-1222

1999

Volltextzugriff (PDF)

Reduced intensity regimen for a second mismatched transplant

Haematologica (Roma), 2001-07, Vol.86 (7), p.780

2001

Volltextzugriff (PDF)

Therapeutic Potential of a Reduced-Intensity Preparative Regimen for Allogeneic Transplantation with Cladribine, Busulfan, and Antithymocyte Globulin against Advanced/Refractory Acute Leukemia/Lymphoma

Clinical cancer research, 2002-04, Vol.8 (4), p.1014-1020

2002

Volltextzugriff (PDF)

Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (8), p.711-719

2004

Volltextzugriff (PDF)

Impact of graft‐versus‐host disease in reduced‐intensity stem cell transplantation (RIST) for patients with haematological malignancies

British journal of haematology, 2003-04, Vol.121 (2), p.296-303

2003

Volltextzugriff (PDF)

Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO‐incompatible donor

British journal of haematology, 2002-07, Vol.118 (1), p.128-131

2002

Volltextzugriff (PDF)

The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

Haematologica (Roma), 2003-01, Vol.88 (1), p.115

2003

Volltextzugriff (PDF)

Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia

Japanese journal of clinical oncology, 2001-01, Vol.31 (1), p.30-34

2001

Volltextzugriff (PDF)

Partially Matched Transplants with Allogeneic CD34+ Blood Cells

Leukemia & lymphoma, 2000, Vol.37 (5-6), p.487-496

2000

Volltextzugriff (PDF)

Elafin is a biomarker of graft-versus-host disease of the skin

Science translational medicine, 2010-01, Vol.2 (13), p.13ra2

2010

Volltextzugriff (PDF)

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Blood, 2008-02, Vol.111 (4), p.2470-2475

2008

Volltextzugriff (PDF)

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

Blood, 2019-02, Vol.133 (7), p.754-762

2019

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(33)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'

Endoscopic evaluation for cytomegalovirus enterocolitis after allogeneic haematopoietic stem cell transplantation

Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation

Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies

Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity

Reduced intensity regimen for a second mismatched transplant

Therapeutic Potential of a Reduced-Intensity Preparative Regimen for Allogeneic Transplantation with Cladribine, Busulfan, and Antithymocyte Globulin against Advanced/Refractory Acute Leukemia/Lymphoma

Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution

Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party

Impact of graft‐versus‐host disease in reduced‐intensity stem cell transplantation (RIST) for patients with haematological malignancies

Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO‐incompatible donor

The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia

Partially Matched Transplants with Allogeneic CD34+ Blood Cells

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Elafin is a biomarker of graft-versus-host disease of the skin

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

Aktive Filter

Suchergebnisse filtern